logo
Share SHARE
FONT-SIZE Plus   Neg

Wal-Mart Names Enrique Ostale EVP, President And CEO Of Walmart Latin America

Wal-Mart Stores Inc. (WMT) announced Friday that Enrique Ostale, president and CEO of Walmart Chile, formerly D&S, has been named executive vice president, president and CEO of Walmart Latin America, where he will oversee Walmart's operations in Argentina, Brazil, Chile, Costa Rica, El Salvador, Guatemala, Honduras, Mexico and Nicaragua.

Based in Walmart's Latin American regional office in Mexico City, Ostale will assume his new role on March 1st. Eduardo Solorzano will retire as president and CEO of Walmart Latin America and continue to serve as chairman of the board of directors at Walmart de Mexico.

Ostale joined D&S in 1989, serving as the manager of the company's finance division, merchandising division and Lider format division, and then as the CFO. In 2000 Ostale left D&S to serve as CEO of El Mercurio Online, the website for Chile's El Mercurio Newspaper. He later served as dean of the business school of the Adolfo Ibanez University from 2002 to 2006. In 2006, Ostale rejoined D&S as president and CEO. Following Walmart's acquisition of D&S in 2009, Ostale was key in leading D&S's successful transformation to Walmart Chile.

Gian Carlo Nucci, currently executive vice president and COO of Walmart de Mexico, has been named to replace Ostale as president and CEO of Walmart Chile. Nucci joined Walmart de Mexico in 1993 and served in several roles, including responsibilities for all Sam's Club operations in Mexico, before being named vice president, VIPS Restaurants, in 2003. He then served as vice president, Superama, before being promoted to senior vice president, Sam's Club and then executive vice president, Specialized Formats. Nucci was appointed COO of Walmart de Mexico in January, 2010.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year. As the din settles down on a dismal quarter at one of the world's exciting tech company, it is time to sit back and take stock of what went wrong and will the wrong be righted in the near term?
comments powered by Disqus
Follow RTT